PurposeProgressive degenerative diseases that affect the TMJ, such as osteoarthritis (OA), juvenile idiopathic arthritis (JIA), and idiopathic condylar resorption (ICR), are characterized by ongoing loss of articular fibrocartilage, subchondral bone remodeling, and synovitis.1 These structures can be preserved by reducing inflammation and thereby slowing the progressive catabolic cellular processes underlying the pathogenesis of these conditions.1 Given that mesenchymal stem cells and their derivatives have now been employed in the treatment of numerous systemic pro-inflammatory conditions with promising outcomes, the goal of this study was to investigate the anti-inflammatory effects of human umbilical cord perivascular mesenchymal cells (HUCPVCS) and a cell lysate (CL) derived therefrom in an established hind-paw model of carrageenan-induced inflammation, then further evaluate their anti-inflammatory potential in a model of temporomandibular joint inflammation.2 MethodsFemale CD1 mice (n = 8 per group) underwent hind-paw injections of carrageenan for induction of inflammation, followed by treatment with saline (control), 1% CL, or HUCPVCS. Tissue edema was assessed by measuring paw circumference prior to injections and 48 hours later. Hind paws were excised post-sacrifice to assess MPO and TNF-alpha concentrations. Male Wistar rats (n = 8 per group) underwent intra-articular TMJ injections of either saline followed by carrageenan (control), 1% CL, or viable HUCPVCS. Rats were sacrificed at 4 and 48 hours post-injection. Articular tissue as well as synovial aspirates were obtained for histologic analysis and to assess leukocyte infiltration. The effects of CL and HUCPVCS on TNF-alpha and MPO concentrations were analyzed using 1-way ANOVA and post-hoc Tukey tests for pairwise comparisons between means of groups, while linear regression modeling was utilized to assess differences in leukocyte infiltration. ResultsFor the results, 1% CL and HUCPVC-treated hind paws demonstrated a reduction tissue edema and significantly lower concentrations of MPO and TNF-alpha 48 hours post-injection compared to controls. Treated TMJs demonstrated lower concentrations of leukocytes in the synovium post-Injection compared to controls. Histologic analysis of the TMJs from treatment groups demonstrated a reduction in signs of acute inflammation when compared to controls. ConclusionHUCPVCs and their CL derivatives reduced tissue edema, levels of pro-inflammatory mediators, leukocyte infiltration, while modulating signs of TMJ inflammation histologically.
Read full abstract